A carregar...
Biosimilars in the management of neutropenia: focus on filgrastim
Advances in chemotherapy and surgery allows the majority of patients to survive cancer diseases. Yet, the price may be a proportion of patients dying of complications due to treatment-induced infectious complications, such as neutropenia. With the aim of decreasing morbidity and mortality related to...
Na minha lista:
| Publicado no: | Biologics |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4762467/ https://ncbi.nlm.nih.gov/pubmed/26937170 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S73580 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|